Here’s what you should know:
1. The company plans to offer some of the Deerfield employees jobs in Boston, a Takeda spokesperson said in a statement to the Tribune.
2. Takeda plans to move the work being done at the company’s Deerfield location to the greater Boston area if the company’s planned $64.2 billion acquisition of Shire is completed.
3. Takeda could close the Shire deal in the first half of 2019.
4. Within the first six months of the deal’s closure, Takeda will notify employees if they’ve been laid off. Following the completion of the deal, Takeda will lay off up to 7 percent of its global workforce.
5. Several Takeda shareholders have come out against the Shire deal, including Kazu Takeda — a member of Takeda’s founding family.
6. Takeda had been consolidating services across the U.S. to its Boston location for the past several years. Takeda plans to keep its Washington, D.C., Minnesota and San Diego locations active.
More articles on gastroenterology:
ASC supply chain tip of the day: Copy what works at hospitals
Outpatient arthroplasty patients would choose to undergo surgery again: 4 study facts
5 key facts about The Joint Commission’s accreditation and certification decisions
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.